The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Immune responses limit adenovirally mediated gene expression in the adult mouse eye
Abstract
In order to investigate the immunological consequences of gene transfer to the eye using viral vectors, adenovirus carrying a lacZ reporter gene (AV.LacZ) was injected either subretinally, subconjunctivally or into the anterior chamber of three groups of adult mice: immunocompetent or transiently immunosuppressed BALB/c mice and congenic immunodeficient nude mice. Adenovirally mediated lacZ expression persisted for approximately 3 weeks following injection of the vector into the anterior chamber, retina or extra ocular tissues of the conjuctiva of BALB/c mice. It appears that T cell-mediated immune responses limit the duration of AV-mediated ocular gene expression in adult mice since lacZ gene expression was detected for at least 15 weeks in T cell-deficient BALB/c nude mice, although the level of transgene expression decreased with time. Since intra-ocular AV-mediated gene expression was not significantly longer than extra-ocular expression, it appears that the eye is not normally immune-privileged with respect to viral vectors. Inflammatory cells were detected in the vitreous after anterior chamber injection and in the retina after subretinal injection of adenovirus. The presence of both CD4+ and CD8+ T cells was established by immunophenotyping. Reinjection of BALB/c mice resulted in rapid decline in reporter gene expression, but successful readministration was possible in the case of immunodeficient nude mice. However, after transient depletion of T cells, achieved by intraperitoneal injection of both CD8- and CD4-specific antibodies, the duration of expression in BALB/c mice was longer in the eye (at least 12 weeks, again with decrease in level over time), than in extra-ocular tissues (8 weeks) provided the animal was not reinjected with virus raising the possibility of partial ocular immune-privilege after transient immunosuppression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In order to investigate the immune consequences of Ad, three groups of adult mice were injected with Ad carrying a lacZ reporter gene into immunocompetent, transiently immunosuppressed BALB/c mice and congenital, immunodeficient nude mice.CD4 + and CD8 + T-cell infiltration was observed in retinal sections, and anti-Ad antibodies were also measured in the immunocompetent mice.The transgene”
From Immune responses to gene editing by viral and non-viral delivery vectors used in retinal gene therapy (2022) · cites this paper as [63]
Citations
Cites
Cellular immune reactivity within the CNS
Wekerle, H., Linington, C., Lassmann, H., & Meyermann, R. (1986) · Trends in Neurosciences · doi:10.1016/0166-2236(86)90077-9 · Cited by 774
Manipulation of Adenovirus Vectors
Graham, F. L., & PREVEC, L. (2003) · Humana Press eBooks · doi:10.1385/0-89603-178-0:109 · Cited by 748
A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells
Zolotukhin, S., Potter, M., Hauswirth, W. W., Guy, J., & Muzyczka, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4646-4654.1996 · Cited by 609
Dai, Y., Schwarz, E. M., Gu, D., Zhang, W., Sarvetnick, N., & Verma, I. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1401 · Cited by 590
Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance
Cobbold, S. P., Martín, G., QIN, S., & Waldmann, H. (1986) · Nature · doi:10.1038/323164a0 · Cited by 335
Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy
Bennett, J., Tanabe, T., Sun, D., Zeng, Y., Kjeldbye, H., Gouras, P., & Maguire, A. M. (1996) · Nature Medicine · doi:10.1038/nm0696-649 · Cited by 316
Adenovirus gene transfer causes inflammation in the brain
Byrnes, A. P., Rusby, J. E., Wood, M. J. A., & Charlton, H. M. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00068-t · Cited by 276
Immune Privilege and Immune Regulation in the Eye
Niederkorn, J. Y. (1990) · Advances in immunology · doi:10.1016/s0065-2776(08)60755-5 · Cited by 266
Gene transfer into the mouse retina mediated by an adeno-associated viral vector
Ali, R. R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.5.591 · Cited by 258
Self-citationYang, Y., Trinchieri, G., & Wilson, J. M. (1995) · Nature Medicine · doi:10.1038/nm0995-890 · Cited by 243
Cited by
Sorted by citations
Pharmaceutical development of AAV-based gene therapy products for the eye
Rodrigues, G. A., Shalaev, E., Karami, T. K., Cunningham, J., Slater, N. K. H., & Rivers, H. M. (2019) · Pharmaceutical Research · doi:10.1007/s11095-018-2554-7 · Cited by 213
Bainbridge, J., Stephens, C., Parsley, K., Demaison, C., Halfyard, A., Thrasher, A., & Ali, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301574 · Cited by 197
Self-citationVector platforms for gene therapy of inherited retinopathies
Trapani, I., Puppo, A., & Auricchio, A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.08.001 · Cited by 191
Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1
Bainbridge, J. W., Mistry, A., de Alwis, M., Paleolog, E. M., Baker, A. H., Thrasher, A. J., & Ali, R. R. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301680 · Cited by 155
Self-citationAAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa
Smith, A. J., Schlichtenbrede, F. C., Tschernutter, M., Bainbridge, J. W., Thrasher, A. J., & Ali, R. R. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00144-8 · Cited by 141
Self-citationCell Transplantation as a Treatment for Retinal Disease
Lund, R. D., Kwan, A., Keegan, D., Sauvé, Y., Coffey, P. J., & Lawrence, J. M. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00003-9 · Cited by 132
Immune response following intraocular delivery of recombinant viral vectors
Bennett, J. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302030 · Cited by 111
Let There Be Light: Gene and Cell Therapy for Blindness
Dalkara, D., Goureau, O., Marazova, K., & Sahel, J. (2016) · Human Gene Therapy · doi:10.1089/hum.2015.147 · Cited by 141
Tschernutter, M., Schlichtenbrede, F. C., Howe, S. J., Balaggan, K. S., Munro, P., Bainbridge, J. W., Thrasher, A. J., Smith, A. J., & Ali, R. R. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302460 · Cited by 132
Self-citationSarra, G. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.21.2353 · Cited by 127
Clinical applications of retinal gene therapy
Lipinski, D. M., Thake, M., & MacLaren, R. E. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.09.001 · Cited by 123
AAV-mediated gene therapy for retinal disorders: from mouse to man
Buch, P. K., Bainbridge, J. W., & Ali, R. R. (2008) · Gene Therapy · doi:10.1038/gt.2008.66 · Cited by 124
Self-citationWeise, J., Isenmann, S., Klöcker, N., Kügler, S., Hirsch, S., Gravel, C., & Bähr, M. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0285 · Cited by 118
Harvey, A. R., Kamphuis, W., Eggers, R., Symons, N. A., Blits, B., Niclou, S., Boer, G. J., & Verhaagen, J. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1168 · Cited by 114
Gene therapy and transplantation in CNS repair: The visual system
Harvey, A. R., Hu, Y. J., Leaver, S. G., Mellough, C., Park, K. K., Verhaagen, J., Plant, G. W., & Cui, Q. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.07.002 · Cited by 110
Croxford, J. L., Feldmann, M., Chernajovsky, Y., & Baker, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4124 · Cited by 98
Self-citationModulating conjunctival wound healing
Cordeiro, M. F., Chang, L., Lim, K. S., Daniels, J. T., Pleass, R. D., Siriwardena, D., & Khaw, P. T. (2000) · Eye · doi:10.1038/eye.2000.141 · Cited by 93
Gene therapy for retinal ganglion cell neuroprotection in glaucoma
Wilson, A. M., & Polo, A. D. (2011) · Gene Therapy · doi:10.1038/gt.2011.142 · Cited by 81
Klausner, E. A., Peer, D., Chapman, R. L., Multack, R. F., & Andurkar, S. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.041 · Cited by 80
Ishikawa, H., Takano, M., Matsumoto, N., Sawada, H., Ide, C., Mimura, O., & Dezawa, M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302277 · Cited by 78
Advances in gene therapy technologies to treat retinitis pigmentosa
Petrs‐Silva, H., & Linden, R. (2013) · Clinical ophthalmology · doi:10.2147/opth.s38041 · Cited by 81
Ocular gene therapy: current progress and future prospects
Colella, P., Cotugno, G., & Auricchio, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.11.003 · Cited by 72
Anand, V., Duffy, B., Yang, Z., Dejneka, N. S., Maguire, A. M., & Bennett, J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0525 · Cited by 69
Inhibition of Corneal Neovascularization by Recombinant Adenovirus Mediated Antisense VEGF RNA
Lai, C., Spilsbury, K., Brankov, M., Zaknich, T., & Rakoczy, P. E. (2002) · Experimental Eye Research · doi:10.1006/exer.2002.2075 · Cited by 64
Kawakami, S., Harada, A., Sakanaka, K., Nishida, K., Nakamura, J., Sakaeda, T., Ichikawa, N., Nakashima, M., & Sasaki, H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.013 · Cited by 58
Gene supplementation therapy for recessive forms of inherited retinal dystrophies
Smith, A. J., Bainbridge, J. W., & Ali, R. R. (2011) · Gene Therapy · doi:10.1038/gt.2011.161 · Cited by 60
Self-citationYamashita, T., Sonoda, S., Suzuki, R., Arimura, N., Tachibana, K., Maruyama, K., & Sakamoto, T. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.08.006 · Cited by 54
Retinal transplantation: progress and problems in clinical application
Lund, R. D., Ono, S. J., Keegan, D., & Lawrence, J. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0103041 · Cited by 54
Smith, J. R., Verwaerde, C., Rolling, F., Naud, M., Delanoye, A., Thillaye-Goldenberg, B., Apparailly, F., & de Kozak, Y. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1037 · Cited by 53
Ren, D., Fisson, S., Dalkara, D., & Ail, D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091973 · Cited by 52
Marked inhibition of retinal neovascularization in rats following soluble‐flt‐1 gene transfer
Rota, R., Riccioni, T., Zaccarini, M., Lamartina, S., Gallo, A. D., Fusco, A., Kovesdi, I., Balestrazzi, E., ABENI, D. D., Ali, R. R., et al. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.586 · Cited by 52
Self-citationAdeno-associated and Herpes Simplex Viruses as Vectors for Gene Transfer to the Corneal Endothelium
Hudde, T., Rayner, S. A., de Alwis, M., Thrasher, A. J., Smith, J., Coffin, R. S., George, A. J. T., & Larkin, F. (2000) · Cornea · doi:10.1097/00003226-200005000-00022 · Cited by 51
Self-citationGene Therapy of Inherited Retinopathies: A Long and Successful Road from Viral Vectors to Patients
Colella, P., & Auricchio, A. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.123 · Cited by 54
Bemelmans, A., Bonnel, S., Houhou, L., Dufour, N., Nandrot, E. F., Helmlinger, D., Sarkis, C., Abitbol, M. M., & Mallet, J. J. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.788 · Cited by 50
Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells
Peeters, L., Sanders, N. N., Jones, A. T., Demeester, J., & Smedt, S. C. D. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.033 · Cited by 50
Gene therapy for ocular angiogenesis
Bainbridge, J. W., Mistry, A., Thrasher, A. J., & Ali, R. R. (2003) · Clinical Science · doi:10.1042/cs20020314 · Cited by 50
Self-citationGene transfer mediated by recombinant baculovirus into mouse eye.
Haeseleer, F., Imanishi, Y., Saperstein, D. A., & Palczewski, K. (2001) · PubMed · Cited by 50
Kreppel, F., Luther, T. T., Semkova, I., Schraermeyer, U., & Kochanek, S. (2002) · PubMed · Cited by 46
Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases
Yu, W., & Wu, Z. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.011 · Cited by 48
Amaral, J., Fariss, R. N., Campos, M. M., Robison, W. G., Kim, H., Lutz, R., & Becerra, S. P. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0492 · Cited by 43
Barriers for retinal gene therapy: separating fact from fiction.
Kumar-Singh, R. (2008) · Vision Research · doi:10.1016/j.visres.2008.05.005 · Cited by 43
Ribozyme uses in retinal gene therapy
Hauswirth, W. W., & Lewin, A. S. (2000) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(00)00007-0 · Cited by 39
Dorigo, O., Gil, J. S., Gallaher, S. D., Tan, B. T., Castro, M. G., Lowenstein, P. R., Calos, M. P., & Berk, A. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6556-6566.2004 · Cited by 38
Molecular therapy in ocular wound healing
Cordeiro, M. F., Schultz, G., Ali, R. R., Bhattacharya, S. S., & Khaw, P. T. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.11.1219 · Cited by 36
Self-citationDelivery of anti-angiogenic molecular therapies for retinal disease
Anderson, O. A., Bainbridge, J. W., & Shima, D. T. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.02.004 · Cited by 34
Gene Therapy for Inherited Retinal Degeneration
Arbabi, A., Liu, A., & Ameri, H. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0087 · Cited by 30
Ikeda, Y., Goto, Y., Yonemitsu, Y., Miyazaki, M., Sakamoto, T., Ishibashi, T., Tabata, T., Ueda, Y., Hasegawa, M., Tobimatsu, S., et al. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301973 · Cited by 30
Ikeda, Y., Yonemitsu, Y., Sakamoto, T., Ishibashi, T., Ueno, H., Kato, A., Nagai, Y., Fukumura, M., Inomata, H., Hasegawa, M., et al. (2002) · Experimental Eye Research · doi:10.1006/exer.2002.1177 · Cited by 29
Sustained expression after nonviral ocular gene transfer using mammalian promoters
Kachi, S., Esumi, N., Zack, D. J., & Campochiaro, P. A. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302700 · Cited by 30
Ali, R. R., Reichel, M., Byrnes, A. P., Stephens, C., Thrasher, A. J., Baker, D., Hunt, D. M., & Bhattacharya, S. S. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300761 · Cited by 28
Self-citationNon-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders
Cavalieri, V., Baiamonte, E., & Iacono, M. L. (2018) · Viruses · doi:10.3390/v10060316 · Cited by 29
Mannermaa, E., Rönkkö, S., Ruponen, M., Reinisalo, M., & Urtti, A. O. (2005) · Current Eye Research · doi:10.1080/02713680590934058 · Cited by 28
Derksen, T. A., Sauter, S. L., & Davidson, B. L. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.267 · Cited by 28
Gene Therapy for Genetic and Acquired Retinal Diseases
Chaum, E., & Hatton, M. P. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00336-3 · Cited by 28
The possibility of gene therapy for the treatment of choroidal neovascularization
Murata, T. (2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00147-0 · Cited by 26
Fang, I., Lin, C., Yang, C., Chiang, B., Yang, C., Chau, L., & Chen, M. (2005) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2005.21.420 · Cited by 25
Viral-vector-delivered anti-angiogenic therapies to the eye
Koponen, S., Kokki, E., Kinnunen, K., & Ylä-Herttuala, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020219 · Cited by 24
Sundaram, V., Moore, A. T., Ali, R. R., & Bainbridge, J. W. (2011) · European Journal of Pediatrics · doi:10.1007/s00431-011-1615-2 · Cited by 24
Self-citationGupta, A. R., Dejneka, N. S., D’Amato, R. J., Yang, Z., Syed, N. A., Maguire, A. M., & Bennett, J. (2001) · The Journal of Gene Medicine · doi:10.1002/1521-2254(200105/06)3:3 · Cited by 17
Gene therapy for retinal and choroidal diseases
Campochiaro, P. A. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.5.537 · Cited by 23
Shen, W.-Y., & Rakoczy, P. E. (2001) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729001317022250 · Cited by 20
Shen, W. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.7.1033 · Cited by 20
CRISPR Systems Suitable for Single AAV Vector Delivery
Stevanovic, M., Piotter, E., McClements, M. E., & MacLaren, R. E. (2021) · Current Gene Therapy · doi:10.2174/1566523221666211006120355 · Cited by 19
Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy
Crabtree, E. E., Uribe, K., Smith, S. M., Roberts, D. M., Salmon, J. H., Bower, J. J., Song, L., Bastola, P., Hirsch, M. L., & Gilger, B. C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270972 · Cited by 19
Gene Therapy Using Stem CellsPreprint
Burnight, E. R., Wiley, L. A., Mullins, R. F., Stone, E. M., & Tucker, B. A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017434 · Cited by 20
Sakamoto, T., Ikeda, Y., & Yonemitsu, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00191-0 · Cited by 18
Commentary: An Aye for Eye Gene Therapy
Bennett, J. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.177 · Cited by 18
Daniels, D. M., Shen, W., Constable, I. J., & Rakoczy, P. E. (2003) · Clinical and Experimental Ophthalmology · doi:10.1046/j.1442-9071.2003.00693.x · Cited by 17
Reichel, M. B. (2001) · British Journal of Ophthalmology · doi:10.1136/bjo.85.3.341 · Cited by 17
Self-citationAbsence of PKR Attenuates the Anti-HSV-1 Activity of an Adenoviral Vector Expressing Murine IFN- β
Al-Khatib, K., Williams, B. R. G., Silverman, R. H., Halford, W. P., & Carr, D. J. J. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002760274872 · Cited by 16
Gene therapy in immune-mediated diseases of the eye
Pleyer, U. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00046-0 · Cited by 16
Hou, Y., Lin, X., Fu, S., Zhang, X., Liu, J., Liu, H., Lv, B., & Cui, H. Z. (2009) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-008-1023-0 · Cited by 15
Ikeda, Y., Yonemitsu, Y., Miyazaki, M., Kohno, R.-I., Murakami, Y., Murata, T., Goto, Y., Tabata, T., Ueda, Y., Ono, F., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.048 · Cited by 15
Gene therapy for ocular neovascularization: a cure in sight
Reich, S. J., & Bennett, J. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00043-1 · Cited by 15
Prospects for gene therapy of inherited retinal disease
Bainbridge, J. W. (2009) · Eye · doi:10.1038/eye.2008.412 · Cited by 12
Ex vivo adenovirus mediated gene transfection of human conjunctival epithelium
Shen, J. (2001) · British Journal of Ophthalmology · doi:10.1136/bjo.85.7.861 · Cited by 12
Remote Adenoviral Gene Delivery to the Spinal Cord: Contralateral Delivery and Reinjection
Turner, D. E., Noordmans, A. J., Feldman, E. L., & Boulis, N. M. (2001) · Neurosurgery · doi:10.1097/00006123-200106000-00026 · Cited by 12
Conotoxins and their potential pharmaceutical applications
Adams, D. J., Alewood, P. F., Craik, D. J., Drinkwater, R. D., & Lewis, R. J. (1999) · Drug Development Research · doi:10.1002/(sici)1098-2299(199903/04)46:3/4 · Cited by 104
Zinkernagel, M. S., McMenamin, P. G., Forrester, J. V., & Degli‐Esposti, M. A. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.04.001 · Cited by 11
La conception de vecteurs adaptés à la thérapie génique oculaire
Khabou, H., & Dalkara, D. (2015) · médecine/sciences · doi:10.1051/medsci/20153105015 · Cited by 11
Bemelmans, A., Kostic, C., Hornfeld, D., Jaquet, M., Crippa, S. V., Hauswirth, W. W., Lem, J., Wang, Z., Schorderet, D. F., Munier, F. L., et al. (2006) · Advances in experimental medicine and biology · doi:10.1007/0-387-32442-9_35 · Cited by 10
Wang, Y., Xie, J., Yarber, F., Mazurek, C., Trousdale, M. D., Medina‐Kauwe, L. K., Kasahara, N., & Hamm‐Alvarez, S. F. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302247 · Cited by 10
Lai, C., Shen, W., Constable, I. J., & Rakoczy, P. E. (1999) · Current Eye Research · doi:10.1076/ceyr.19.5.411.5288 · Cited by 9
In vivo gene transfer into choroidal neovascularization by the HVJ liposome method
Otsuji, T., Ogata, N., Takahashi, K. A., Matsushima, M., Uyama, M., & Kaneda, Y. (2000) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s004170050032 · Cited by 7
Immunosuppression by IL-10-transfected human retinal pigment epithelial cells in vitro
Enzmann, V., Hollborn, M., Poschinger, K., Wiedemann, P., & Kohen, L. (2001) · Current Eye Research · doi:10.1076/ceyr.23.2.98.5474 · Cited by 5
Periocular Triamcinolone Enhances Intraocular Gene Expression after Delivery by Adenovirus
Park, C. Y., Chuck, R. S. H., Cano, M., Yew, M., Nguyen, V. Q., Parker, J., Mori, K., & Gehlbach, P. L. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0619 · Cited by 4
Gene Therapy in Age-related Macular Degeneration
Zhou, H. W., & Kim, L. A. (2025) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000567 · Cited by 2
Gehlbach, P. L., Chuck, R. S. H., Park, C., & Park, C. Y. (2012) · Molecular Imaging · doi:10.2310/7290.2011.00053 · Cited by 1
Gene therapy for Stargardt and other ABCA4-related diseases: lessons from RPE65-LCA trials
Silva, N. F. A. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Mosallaei, M. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.08.003 · Cited by 1
Mehryar, M., Mosallaei, M., Ashraf, H., Rezasadeh, S., Azarpira, N., Tanideh, N., & Mehrabani, D. (2009) · Iranian Red Crescent Medical Journal · Cited by 1
Rakoczy, E. P., Shen, W., Spilsbury, K., Yu, M., Lai, M. C., Barry, C. J., & Constable, I. J. (1999) · Cited by 1
Remote Adenoviral Gene Delivery to the Spinal Cord: Contralateral Delivery and Reinjection
Turner, D. E., Noordmans, A. J., Feldman, E. L., & Boulis, N. M. (2001) · Neurosurgery · doi:10.1227/00006123-200106000-00026 · Cited by 1
Novel Methods to Eliminate the Immune Response to Adenovirus Gene Therapy
Zhang, H., Hsu, H., & Mountz, J. D. (2002) · Elsevier eBooks · doi:10.1016/b978-012199504-1/50015-8 · Cited by 1
Development Of Rat Models For Choroidal Neovascularisation (CNV)
Rakoczy, P. E., Shen, W., Spilsbury, K., Yu, M., Lai, M. C., Barry, C. J., & Constable, I. J. (2007) · Springer eBooks · doi:10.1007/978-0-585-33172-0_36
EUROPEAN SCHOOL OF MOLECULAR MEDICINE
Napoli, S. D. (2010)
Anti-Angiogenic Gene Therapy: Basic Science and Challenges for Translation into the Clinic
Lange, C., & Bainbridge, J. W. (2016) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-319-24097-8_11
New Experimental Therapeutic Approaches for Degenerative Diseases of the Retina
Tombran‐Tink, J. (2021) · Routledge eBooks · doi:10.4324/9781003113423-23
Metadata
- Authors
- Reichel, M., Ali, R., Thrasher, A., Hunt, D., Bhattacharya, S., & Baker, D.
- Affiliations
- University College London (GB)
- ORCID
- Baker, D
- Venue
- Gene Therapy
- Published
- 1998-08-01
- Volume
- 5
- Issue
- 8
- Pages
- 1038-1046
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2047633827
- Cited by
- 106
- References
- 34
- Citations by year
- 2026: 1 · 2025: 1 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 2 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 4
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- adenoviral vector, immune privilege, T cell immunity, subretinal injection, anterior chamber injection, subconjunctival injection, nude mice, immunodeficient mice, transient immunosuppression, CD4+ T cells, CD8+ T cells, vitreous inflammation, ocular immunology
- MeSH terms
- Adenoviridae, Animals, Anterior Chamber, Antibodies, Antibodies, Viral, beta-Galactosidase, Blood-Retinal Barrier, Conjunctiva, Eye, Genetic Vectors, Immunosuppression Therapy, Injections, Retina, T-Lymphocytes, Time Factors, Transfection, Genetic Therapy, Gene Expression, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review